Article | Published:

Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells

Nature Immunologyvolume 19pages954962 (2018) | Download Citation

Abstract

Controlling the balance between immunity and immunopathology is crucial for host resistance to pathogens. After infection, activation of the hypothalamic–pituitary–adrenal (HPA) axis leads to the production of glucocorticoids. However, the pleiotropic effects of these steroid hormones make it difficult to delineate their precise role(s) in vivo. Here we found that the regulation of natural killer (NK) cell function by the glucocorticoid receptor (GR) was required for host survival after infection with mouse cytomegalovirus (MCMV). Mechanistically, endogenous glucocorticoids produced shortly after infection induced selective and tissue-specific expression of the checkpoint receptor PD-1 on NK cells. This glucocorticoid–PD-1 pathway limited production of the cytokine IFN-γ by spleen NK cells, which prevented immunopathology. Notably, this regulation did not compromise viral clearance. Thus, the fine tuning of NK cell functions by the HPA axis preserved tissue integrity without impairing pathogen elimination, which reveals a novel aspect of neuroimmune regulation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936–941 (2012).

  2. 2.

    Webster, J. I., Tonelli, L. & Sternberg, E. M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20, 125–163 (2002).

  3. 3.

    Irwin, M. R. & Cole, S. W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 11, 625–632 (2011).

  4. 4.

    Cain, D. W. & Cidlowski, J. A. Immune regulation by glucocorticoids. Nat. Rev. Immunol. 17, 233–247 (2017).

  5. 5.

    Weikum, E. R., Knuesel, M. T., Ortlund, E. A. & Yamamoto, K. R. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat. Rev. Mol. Cell Biol. 18, 159–174 (2017).

  6. 6.

    Quatrini, L. et al. Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells. J. Exp. Med. 214, 3531–3541 (2017).

  7. 7.

    Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K. & Muglia, L. J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109, 4313–4319 (2007).

  8. 8.

    Li, C. C., Munitic, I., Mittelstadt, P. R., Castro, E. & Ashwell, J. D. Suppression of dendritic cell-derived IL-12 by endogenous glucocorticoids is protective in LPS-induced sepsis. PLoS Biol. 13, e1002269 (2015).

  9. 9.

    Kleiman, A. et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 26, 722–729 (2012).

  10. 10.

    Jamieson, A. M., Yu, S., Annicelli, C. H. & Medzhitov, R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 7, 103–114 (2010).

  11. 11.

    Ruzek, M. C., Miller, A. H., Opal, S. M., Pearce, B. D. & Biron, C. A. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185, 1185–1192 (1997).

  12. 12.

    Ruzek, M. C., Pearce, B. D., Miller, A. H. & Biron, C. A. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J. Immunol. 162, 3527–3533 (1999).

  13. 13.

    Rhen, T. & Cidlowski, J. A. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N. Engl. J. Med. 353, 1711–1723 (2005).

  14. 14.

    Orange, J. S. & Biron, C. A. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156, 4746–4756 (1996).

  15. 15.

    Orange, J. S. & Biron, C. A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-? production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156, 1138–1142 (1996).

  16. 16.

    Weizman, O. E. et al. ILC1 confer early host protection at initial sites of viral infection. Cell 171, 795–808 (2017).

  17. 17.

    Krmpotic, A., Bubic, I., Polic, B., Lucin, P. & Jonjic, S. Pathogenesis of murine cytomegalovirus infection. Microbes Infect. 5, 1263–1277 (2003).

  18. 18.

    Loh, J., Chu, D. T., O'Guin, A. K., Yokoyama, W. M. & Virgin, H. W. Natural killer cells utilize both perforin and ? interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79, 661–667 (2005).

  19. 19.

    Biron, C. A. & Tarrio, M. L. Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus. Med. Microbiol. Immunol. (Berl.) 204, 345–354 (2015).

  20. 20.

    Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99–103 (1999).

  21. 21.

    Narni-Mancinelli, E. et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl. Acad. Sci. USA 108, 18324–18329 (2011).

  22. 22.

    Spits, H. et al. Innate lymphoid cells--a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).

  23. 23.

    Ayroldi, E. & Riccardi, C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23, 3649–3658 (2009).

  24. 24.

    Delfino, D. V., Agostini, M., Spinicelli, S., Vito, P. & Riccardi, C. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 104, 4134–4141 (2004).

  25. 25.

    Schmidt, S. et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 11, S45–S55 (2004).

  26. 26.

    Sharpe, A. H. & Pauken, K. E. The diverse functions of the PD1 inhibitory pathway. Nat. Rev. Immunol. 18, 153–167 (2017).

  27. 27.

    Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323–1326 (2002).

  28. 28.

    Chen, Y. et al. Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection. PLoS Pathog. 7, e1001347 (2011).

  29. 29.

    Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T. & Nakanishi, K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70, 281–312 (1998).

  30. 30.

    Pien, G. C., Satoskar, A. R., Takeda, K., Akira, S. & Biron, C. A. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-γ responses during viral infection. J. Immunol. 165, 4787–4791 (2000).

  31. 31.

    Frebel, H. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209, 2485–2499 (2012).

  32. 32.

    Erickson, J. J. et al. Viral acute lower respiratory infections impair CD8+ T cells through PD-1. J. Clin. Invest. 122, 2967–2982 (2012).

  33. 33.

    Tay, C. H. & Welsh, R. M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71, 267–275 (1997).

  34. 34.

    Orange, J. S., Wang, B., Terhorst, C. & Biron, C. A. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182, 1045–1056 (1995).

  35. 35.

    Della Chiesa, M. et al. Features of memory-like and PD-1+ human NK cell subsets. Front. Immunol. 7, 351 (2016).

  36. 36.

    Norris, S. et al. PD-1 expression on natural killer cells and CD8+ T cells during chronic HIV-1 infection. Viral Immunol. 25, 329–332 (2012).

  37. 37.

    Beldi-Ferchiou, A. et al. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma. Oncotarget 7, 72961–72977 (2016).

  38. 38.

    Glaser, R. & Kiecolt-Glaser, J. K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5, 243–251 (2005).

  39. 39.

    Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205–214 (2015).

  40. 40.

    Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56–61 (2015).

Download references

Acknowledgements

We thank F. Tronche (Sorbonne Universités, Université Pierre et Marie Curie, UMR_CR18, Neuroscience, Paris-Seine) for Nr3c1loxP/loxP mice; J. Galluso and P. Morganti for mouse breeding and genotyping; G. Bessou (Centre d’Immunologie de Marseille-Luminy) for the plasmid containing the Ie1 gene; and the Centre d’Immunologie de Marseille-Luminy mouse house and core cytometry facilities. This project received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation program, under grant agreement 648768; from the Agence Nationnale de la Recherche (ANR-14-CE14-0009-01) and from the ARC foundation (PGA120140200817). This work was also supported by institutional grants from INSERM, CNRS, Aix-Marseille University and Marseille-Immunopole to the Centre d’Immunologie de Marseille-Luminy.

Author information

Affiliations

  1. Aix Marseille University, CNRS, INSERM, Centre d’Immunologie de Marseille-Luminy, Marseille, France

    • Linda Quatrini
    • , Elisabeth Wieduwild
    • , Bertrand Escaliere
    • , Jessica Filtjens
    • , Lionel Chasson
    • , Caroline Laprie
    • , Eric Vivier
    •  & Sophie Ugolini
  2. Innate Pharma Research Laboratories, Innate Pharma, Marseille, France

    • Eric Vivier
  3. Service d’Immunologie, Marseille Immunopole, Hôpital de la Timone, Assistance Publique des Hôpitaux de Marseille, Marseille, France

    • Eric Vivier

Authors

  1. Search for Linda Quatrini in:

  2. Search for Elisabeth Wieduwild in:

  3. Search for Bertrand Escaliere in:

  4. Search for Jessica Filtjens in:

  5. Search for Lionel Chasson in:

  6. Search for Caroline Laprie in:

  7. Search for Eric Vivier in:

  8. Search for Sophie Ugolini in:

Contributions

L.Q. designed and performed experiments and analyzed data; E.W. and J.F. performed experiments; B.E. performed RNA-based next-generation sequencing; L.C. processed the histology samples and C.L. performed pathological analysis of those samples; E.V. provided the Ncr1Cre mouse model and advice during the manuscript preparation; S.U. conceived of, designed and directed the study; L.Q. and S.U. wrote the manuscript; and all authors reviewed and provided input on the manuscript.

Competing interests

E.V. is a cofounder and employee of Innate Pharma.

Corresponding author

Correspondence to Sophie Ugolini.

Integrated supplementary information

  1. Supplementary Figure 1 GR expression does not affect NK cell cytotoxic function.

    a, FACS analysis of CD107a surface expression on NK cells from WTNcr1-iCre and GRNcr1-iCre mice: splenocytes were stimulated in vitro 4 h at 37 °C with plate-bound anti-NK1.1 or isotype control Abs, or with PMA and ionomycin, in the presence of 500 nM corticosterone or vehicle alone. Means ± s.d. n = 7 mice, pool of 2 experiments. b, ELISA showing corticosterone concentration in the serum 44 h PI as means ± s.e.m. n = 6 (WTNcr1-iCre NI), n = 5 (GRNcr1-iCre) and n = 7 (WTNcr1-iCre MCMV) mice, pool of 2 experiments. ns = not significant, two-tailed Mann-Whitney test. c, FACS analysis of intracellular granzyme B (GrzB) expression by NK cells in the spleen and liver 44 h PI. The data are shown as FACS histograms with the percentage of GrzB+ cells in each panel, and are representative of 2 experiments with n = 4 mice. d, FACS analysis of intracellular IFN-γ, assessed directly ex vivo without in vitro re-stimulation 44 PI. IFN-γ MFI calculated on IFN-γ+ NK cells is shown as mean ± s.e.m. n = 7 (WTNcr1-iCre) and n = 6 (GRNcr1-iCre) mice, pool of 2 experiments. *P < 0.05, two-tailed Student’s t-test. Each symbol in a and c represents a single mouse.

  2. Supplementary Figure 2 Upon MCMV infection NCR1+ ILC3s in the small intestine are not activated.

    a, NCR1+ ILC3s were gated as: single, live, CD45+, CD3-CD19-, NKp46+Rorγt+. b-d, FACS analysis of intracellular IL-17 and IL-22 in NCR1+ ILC3s in the small intestine 44 h PI. Representative FACS plots (b) and means ± s.d. (c and d). n = 4 (WTNcr1-iCre) and n = 6 (GRNcr1-iCre) mice from 1 experiment. e, frequency of NCR1+ ILC3s among CD45+ cells is shown as mean ± s.e.m., n = 2 (NI), n = 4 (WTNcr1-iCre) and n = 6 (GRNcr1-iCre) mice from one experiment.

  3. Supplementary Figure 3 Gating strategy for the sorting of NCR1+ cells from the spleen and liver.

    FACS plots showing the gating strategy used to sort (a) single, live, CD45+CD3-CD19-NK1.1+NKp46+DX5+ NK cells from splenocytes (after NK cell enrichment), (b) single, live, CD45+CD3-CD19-NK1.1+NKp46+DX5+CD49a- NK cells and single, live, CD45+CD3-CD19-NK1.1+NKp46+DX5-CD49a+ ILC1s from liver lymphocytes 44 h PI.

  4. Supplementary Figure 4 NK cell and ILC1 proliferation and apoptosis are unchanged in MCMV-infected GRNcr1-iCre mice.

    FACS analysis of Ki67 expression (histograms) and PI/Annexin V staining (dot plot) for spleen NK cells (a), liver NK cells (b) and liver ILC1s (c) 44 h PI. Data are also shown as means. For Ki67 data n = 2 (NI), n = 5 (WTNcr1-iCre MCMV) and n = 4 (GRNcr1-iCre MCMV) mice, pool of 2 experiments. For AnnexinV/PI data n = 5 (WTNcr1-iCre) and n = 3 (GRNcr1-iCre) mice, pool of 2 experiments. Each dot represents a single mouse.

  5. Supplementary Figure 5 Endogenous glucocorticoids do not induce PD-1 expression on spleen myeloid cells upon MCMV infection.

    a, gating strategy for DCs (CD11c+MHCIIhi), neutrophils (CD11c-CD11b+Ly6G+) and macrophages (CD11c-CD11b+F4/80+) among lymphocytes of the spleen. b, FACS histograms showing PD-1 staining on spleen macrophages, neutrophils and DCs. MFI (mean fluorescence intensity) is shown on each plot. Data are representative of 2 experiments.

  6. Supplementary Figure 6 GR expression and IL-18 induction in spleen and liver.

    a, FACS histograms showing GR and isotype control intracellular staining in spleen and liver NK cells 44 h PI. The MFI ratio to isotype control is shown in each panel. Data are representative of one experiment. b, qRT-PCR of Il18 from RNA extracted from spleen and liver homogenates 44 h PI. n = 9 (spleen NI), n = 12 (spleen and liver MCMV) and n = 8 (liver NI) mice, pool of 3 experiments. Mean value is shown. Each symbol represents a mouse.

  7. Supplementary Figure 7 There is no correlation between PD-1 and Ly49H expression on NK cells.

    a, FACS analysis of PD-1 expression on NK cells in the spleen 44 h PI. Dot plots showing the proportion of Ly49H+ NK cells (upper panel) and histograms showing PD-1 expression on each subset (lower panel) are representative of 2 experiments. b, percentage of Ly49H+ NK cells in the spleen 5 days PI. Data are shown as mean + /- s.e.m. n = 2 (NI) and n = 6 (MCMV) mice, pool of 2 experiments. Each dot represents a single mouse.

  8. Supplementary Figure 8 Cytokine concentration in serum and organs of MCMV-infected mice.

    Cytometric bead array measurement of (a) IL-6, (b) TNF and (c) IL-10 concentration 3 days PI in the serum, spleen and liver. n = 7 (WTNcr1-iCre and Ig serum), n = 8 (GRNcr1-iCre and PD-1 Ab serum, and WTNcr1-iCre spleen and liver IL-6 and TNF), n = 6 (WTNcr1-iCre spleen and liver IL-10), n = 9 (GRNcr1-iCre spleen and liver IL-10, and Ig and PD-1 Ab spleen and liver) and n = 3 (WTNcr1-iCre and GRNcr1-iCre serum IL-10) mice. Data are shown as mean + /- s.e.m., pool of 2 experiments (with the exception of serum IL-10 data from WTNcr1-iCre and GRNcr1-iCre mice that are representative of one experiment). Two-tailed Mann-Whitney test was performed for a serum WTNcr1-iCre and GRNcr1-iCre, b serum, b liver WTNcr1-iCre and GRNcr1-iCre, and c serum Ig and PD1-Ab samples. Student’s t-test was performed for all the other pairs of data. For all comparisons P > 0.05. Each dot represents a single mouse.

Supplementary information

  1. Supplementary Text and Figures

    Supplementary Figures 1-8 and Supplementary Table 1

  2. Reporting Summary

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41590-018-0185-0